C3 glomerulonephritis secondary to mutations in factors H and I: rapid recurrence in deceased donor kidney transplant effectively treated with eculizumab.
| Author | |
|---|---|
| Abstract |
:
C3 glomerulonephritis (C3GN) is caused by alternate complement pathway over-activation. It frequently progresses to end-stage renal disease, recurs in two-thirds of transplants and in half of these cases progresses to allograft loss. There is currently no proven treatment for C3GN. |
| Year of Publication |
:
2018
|
| Journal |
:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
|
| Date Published |
:
2018
|
| ISSN Number |
:
0931-0509
|
| URL |
:
https://academic.oup.com/ndt/article-lookup/doi/10.1093/ndt/gfx369
|
| DOI |
:
10.1093/ndt/gfx369
|
| Short Title |
:
Nephrol Dial Transplant
|
| Download citation |
